Literature DB >> 2387297

Concentrations of temafloxacin in serum and bronchial mucosa.

D R Baldwin1, L Wilkinson, J M Andrews, J P Ashby, R Wise, D Honeybourne.   

Abstract

The bronchial mucosal concentrations of temafloxacin hydrochloride were determined in specimens obtained at fibreoptic bronchoscopy and compared with simultaneous serum concentrations. The 18 patients studied were given an oral dose of 400 mg b.i.d for three days to achieve steady state levels. The mean serum concentration was 6.9 mg/l (SD 2.5 mg/l) and the mean bronchial mucosal concentration 12.2 mg/kg (SD 4 mg/kg). The mucosal levels exceeded those required to inhibit most of the common respiratory pathogens, including Streptococcus pneumoniae and Pseudomonas aeruginosa. These data support the use of temafloxacin for therapy of bronchial infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387297     DOI: 10.1007/bf01979477

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

Review 1.  Bacterial colonization: pathogenesis and clinical significance.

Authors:  L B Palmer
Journal:  Clin Chest Med       Date:  1987-09       Impact factor: 2.878

2.  Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.

Authors:  D Honeybourne; J M Andrews; J P Ashby; R Lodwick; R Wise
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

Review 3.  Penetration of antibiotics into respiratory secretions.

Authors:  J E Pennington
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

4.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

5.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

6.  Josamycin pulmonary penetration determined by broncho-alveolar lavage in man.

Authors:  G Panteix; R Harf; H de Montclos; M F Verdier; A Gaspar; M Leclercq
Journal:  J Antimicrob Chemother       Date:  1988-12       Impact factor: 5.790

7.  Spiramycin uptake by alveolar macrophages.

Authors:  R Harf; G Panteix; J F Desnottes; N Diallo; M Leclercq
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

8.  Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.

Authors:  W J Wijnands; T B Vree; A M Baars; C L van Herwaarden
Journal:  J Antimicrob Chemother       Date:  1988-02       Impact factor: 5.790

9.  Antibiotic entry into human polymorphonuclear leukocytes.

Authors:  R C Prokesch; W L Hand
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.

Authors:  D J Hardy; R N Swanson; D M Hensey; N R Ramer; R R Bower; C W Hanson; D T Chu; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

View more
  2 in total

Review 1.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Penetration of temafloxacin into body tissues and fluids.

Authors:  F Sörgel
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.